It is also possible that other molecular aberrations, e.g., MiR-15a/16-1, which is as a tumor suppressor that down-regulates WT1 expression in the process of leukemia cell proliferation [22], could be another contributing factor to the observed differences in the WT1 overexpression. The gene discussed is WT1; the disease is leukemia.